New data from a school asthma management program, “Building Bridges for Asthma Care,” presented today at the American Thoracic Society 2015 International Conference, show a significant decrease in school absenteeism among children with asthma from inner-city schools who were enrolled in the program. Absences dropped 11.75 percent among children enrolled in Building Bridges, compared to an increase of 8.48 percent in children with asthma not in the program.
“Building Bridges for Asthma Care” is a school-based program designed to empower nurses in participating elementary schools to ensure that asthmatic children are identified and provided care according to the National Institute of Health’s clinical treatment guidelines. The objectives of the program are addressing the risk of health disparities and asthma-related absenteeism, as well as its related impact on academic achievement for inner city students.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7506851-gsk-building-bridges-for-asthma-care/
As brain health becomes an ever greater concern for people of all ages, the nation’s largest senior living provider is now guiding its residents on developing and putting into practice personalized brain health plans. Brookdale devised the new resident program with the help of a neuropsychologist specializing in brain health. The company is putting it into place at its independent and assisted living communities across the country.
Through the new initiative, Brookdale’s residents will be offered a four-session course that explains key factors in brain health through classroom learning and hands-on activities. Each participant will be guided on creating an individual brain health plan to use on a daily basis. The course was developed with the assistance of Dr. Paul Nussbaum, who is Board Certified in clinical and geropsychology with a specialty in neuropsychology. An adjunct professor of neurological surgery at the University of Pittsburgh, he is the author of “Save Your Brain.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7722157-brookdale-brain-health/
With America’s nursing shortage and the soaring aging population, the nation’s largest senior living provider has launched a student loan reimbursement program with the goal of attracting more nurses to work in assisted living. Brookdale’s initiative comes as the U.S. Bureau of Labor Statistics projects the country’s nurse shortfall will exceed one million by 2022. People 65 and above are expected to comprise 16 percent of America’s population in 2020 and nearly 20 percent in 2030, compared to 13 percent in 2010, according to the U.S. Census Bureau. Brookdale operates more than 1,120 senior living communities in 47 states.
At Brookdale assisted living communities, nurses are hired as health and wellness directors, overseeing clinical services at a community including setting standards, leading health and wellness programming, and managing care associates. “This is a different kind of path than hospital nursing and it is a very important one,” said Kim Estes, senior vice president of clinical services for Brookdale. “Rather than providing hands-on care, these nurses shape the overall quality and content of care their community’s seniors receive on a daily basis.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7722156-brookdale-student-loan-program-nurses/
Phenogen Sciences, Inc. today announced the availability of BREVAGenplus, an easy-to-use predictive risk test for the millions of women at risk of developing sporadic, or non-hereditary, breast cancer. The test is an enhancement of the company’s first generation product, BREVAGen®. BREVAGenplus assesses both clinical risk factors and genetic markers known to be associated with sporadic, or non-hereditary, breast cancer to determine a woman’s five-year and lifetime risk of developing the disease. The test is designed to facilitate better informed decisions about breast cancer screening and preventive treatment plans for Caucasian, Hispanic and African-American women, age 35 years or above, who have not had breast cancer, lobular carcinoma in situ (LCIS) or ductal carcinoma in situ (DCIS), and have one or more risk factors for developing breast cancer.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7337351-phenogen-sciences-introduces-brevagenplus-breast-cancer-risk-assessment-test/
HMR Weight Management Services (HMR), a subsidiary of Merck, has been named a No. 1 Best Fast Weight-Loss Diet in U.S. News & World Report’s Best Diets of 2016 rankings. This is the first year U.S. News has published the Best Fast Weight-Loss Diet category. HMR also held its position as the No. 2 Best Weight-Loss Diet in the annual rankings list for the second year in a row. HMR Programs focus on helping people lose weight quickly while teaching the healthy lifestyle skills needed for long-term weight management.
“HMR programs excel at providing the jump start many people need when beginning a healthier lifestyle program,” said Carol Addy, M.D. MMSc, Chief Medical Officer at HMR. “A common misconception is that losing weight quickly is not healthy, not sustainable, and will just lead to future weight re-gain. To the contrary, numerous clinical studies demonstrate that following a lifestyle change program which promotes fast initial weight loss can result in better long-term success.” Addy added, “On the HMR Program, people can lose weight without feeling hungry. Our programs achieve fast weight loss in a livable way by encouraging people to eat more and stay satisfied, which makes it easier to stick to the program in the short-term, and over the long haul.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7670751-hmr-program-named-best-weight-loss-diet/
Diabetes experts met and determined that some self-monitoring blood glucose (SMBG) systems, despite meeting accuracy standards at the time of U.S. Food and Drug Administration (FDA) clearance, fail to consistently meet accuracy standards once on the market, potentially putting patient health at risk. In a public meeting convened by the Diabetes Technology Society on May 21, 2013, in Arlington, Virginia, leading academic clinicians, clinical chemists, medical device experts, patient advocates and FDA representatives reviewed a growing body of peer-reviewed research demonstrating that the performance of some blood glucose monitors on the market may not be meeting accuracy standards.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/61870-diabetes-technology-society-inaccurate-blood-glucose-monitors-risky
Avigna Clinical Research Institute is modeled on the lines of some of the premier Clinical Research Institutes of India. We are dedicated and committed to provide excellent Clinical Research Professionals to the Clinical Research Industries.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it received 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA) for the BD Veritor™ System for rapid detection of Flu A+B. This is the first rapid influenza test system that incorporates a digital read out of results to receive CLIA waiver.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53615-bd-veritor-system-influenza-test-receives-510k-clearance-fda-clia-waiver
Researchers at global public health organization NSF International, Harvard Medical School, the United States Department of Defense and the National Institute for Public Health and the Environment in the Netherlands (RIVM) recently identified four unapproved, DMAA-like stimulants in six over-the-counter weight-loss and pre-workout products currently available online. The research was published in the peer-reviewed journal Clinical Toxicology.
The potentially harmful compounds – including banned stimulants 1,3-DMAA and 1,3-DMBA as well as octodrine and a newly identified DMAA analog – were not listed as ingredients in the products and may have been disguised as “2-aminoisoheptane” or extract of Aconitum kusnezoffii. These stimulants may cause adverse cardiac events, hemorrhagic strokes or sudden death, especially if taken prior to strenuous exercise or combined with caffeine. Extreme heat and dehydration may also increase the health risks.
To view the multimedia release go to:
https://www.multivu.com/players/English/8216951-nsf-international-banned-stimulants-2-aminoisoheptane/
Inspired by its surrounding southwestern landscape, the Health Sciences Education Building (HSEB) at The University of Arizona College of Medicine-Phoenix is one of the most innovative construction projects in the United States utilizing predominately recycled copper. Using nearly 6,000 copper panels and more than 10,000 copper parts, this 268,000 square-foot building consists of six stories of administration and faculty offices, lecture halls, learning studios, flexible classrooms, clinical suites, gross anatomy facilities, laboratories and conference rooms.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61608-copper-development-green-sustainability-video-case-study-credit-architects
Avon celebrated the brand’s latest innovation, ANEW Clinical Pro Line Eraser Treatment, with flash mobs coast to coast in five cities, including New York, Chicago, Atlanta, Dallas and Los Angeles. Professional ballroom dancer Karina Smirnoff led the moves and wowed the crowd in Los Angeles. Avon Representatives in all cities joined in on the flash mobs and distributed tens of thousands of samples of ANEW Clinical Pro Line Eraser Treatment, which launches this month across the country.
“I can never turn down an opportunity to dance—especially when it’s celebrating such an exciting new innovation like Pro Line Eraser Treatment,” says Smirnoff. “I’m so thrilled to be a part of this big moment for Avon and spending time with the Representatives and fans.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/52897-avon-anew-clinical-pro-line-eraser-treatment-skincare-dermatology
